I like Ros who just joined the board recently, was kind of hoping she would fill the CEO position - but that's purely the way she comes across in interviews.
BIOSHARES removed AD1 from their portfolio purely because of the old CEO Sam leaving, will be interesting if they add it back after this new appointment.
I think they listed pretty early in their development stage, but now is the time to get set for the busy and material catalysts coming up - human trials. Can't say I am totally across their science but yes, the partnership with GE healthcare partly validates their strategy.
Chart- volumes still low, has formed a base, just need to churn through the remaining CR shares around 15c. I hold both heads and options (though they are now very hard to get).
Very quiet stock at the moment - the best time to accumulate if you like the path ahead.
1AD Price at posting:
14.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)